title: Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease.
authors.affiliation: Section of Pediatric Hematology/Oncology, Milwaukee, WI 53226, USA. abrandow@mcw.edu
authors.forename: Amanda M
authors.initials: AM
authors.lastname: Brandow
authors.forename: Julie A
authors.initials: JA
authors.lastname: Panepinto
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D000986:Antisickling Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D003430:Cross-Sectional Studies; D016903:Drug Monitoring / Q000379:methods*; D034742:Electronic Mail; D004909:Erythrocyte Indices / Q000187:drug effects; D005319:Fetal Hemoglobin / Q000032:analysis; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D007958:Leukocyte Count; D020714:Maximum Tolerated Dose; D055118:Medication Adherence; D009504:Neutrophils / Q000187:drug effects; D010976:Platelet Count; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires; D013997:Time Factors; D014481:United States
chemical_list: D000986:Antisickling Agents; D005319:Fetal Hemoglobin; D006918:Hydroxyurea